FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Edward Matelan

Research Profile

Concepts & Ideas

Structure-Activity Relationship

Living Beings

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Robert R Singhaus; Ronald C Bernotas; Robert Steffan; Edward Matelan; Elaine Quinet; Ponnal Nambi; Irene Feingold; Christine Huselton; Anna Wilhelmsson; Annika Goos-Nilsson; Jay Wrobel
3-(3-Aryloxyaryl)imidazo[1,2-a]pyridine sulfones as liver X receptor agonists.
Robert J Steffan; Edward Matelan; Mark A Ashwell; William J Moore; William R Solvibile; Eugene Trybulski; Christopher C Chadwick; Susan Chippari; Thomas Kenney; Richard Winneker; Amy Eckert; Lisa Borges-Marcucci; Steven J Adelman; Zhang Xu; Lidia Mosyak; Douglas C Harnish
Control of chronic inflammation with pathway selective estrogen receptor ligands.
Christopher C Chadwick; Susan Chippari; Edward Matelan; Lisa Borges-Marcucci; Amy M Eckert; James Carl Keith; Leo M Albert; Yelena Leathurby; Heather A Harris; Ramesh A Bhat; Mark A Ashwell; Eugene Trybulski; Richard Winneker; Steven J Adelman; Robert J Steffan; Douglas C Harnish
Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Edward Matelan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Robert R Singhaus; Ronald C Bernotas; Robert Steffan; Edward Matelan; Elaine Quinet; Ponnal Nambi; Irene Feingold; Christine Huselton; Anna Wilhelmsson; Annika Goos-Nilsson; Jay Wrobel
3-(3-Aryloxyaryl)imidazo[1,2-a]pyridine sulfones as liver X receptor agonists.
Bioorganic & medicinal chemistry letters 2010;20(2):521-5.
2006: Robert J Steffan; Edward Matelan; Mark A Ashwell; William J Moore; William R Solvibile; Eugene Trybulski; Christopher C Chadwick; Susan Chippari; Thomas Kenney; Richard Winneker; Amy Eckert; Lisa Borges-Marcucci; Steven J Adelman; Zhang Xu; Lidia Mosyak; Douglas C Harnish
Control of chronic inflammation with pathway selective estrogen receptor ligands.
Current topics in medicinal chemistry 2006;6(2):103-11.
2005: Christopher C Chadwick; Susan Chippari; Edward Matelan; Lisa Borges-Marcucci; Amy M Eckert; James Carl Keith; Leo M Albert; Yelena Leathurby; Heather A Harris; Ramesh A Bhat; Mark A Ashwell; Eugene Trybulski; Richard Winneker; Steven J Adelman; Robert J Steffan; Douglas C Harnish
Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(7):2543-8.
2004: Robert J Steffan; Edward Matelan; Mark A Ashwell; William J Moore; William R Solvibile; Eugene Trybulski; Christopher C Chadwick; Susan Chippari; Thomas Kenney; Amy Eckert; Lisa Borges-Marcucci; James Carl Keith; Zhang Xu; Lidia Mosyak; Douglas C Harnish
Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis.
Journal of medicinal chemistry 2004;47(26):6435-8.
2002: Robert J Steffan; Mark A Ashwell; William R Solvibile; Edward Matelan; Elwood Largis; Stella Han; Jeffery Tillet; Ruth Mulvey
Novel substituted 4-aminomethylpiperidines as potent and selective human beta3-agonists. Part 2: arylethanolaminomethylpiperidines.
Bioorganic & medicinal chemistry letters 2002;12(20):2963-7.
2002: Robert J Steffan; Mark A Ashwell; William R Solvibile; Edward Matelan; Elwood Largis; Stella Han; Jeffery Tillet; Ruth Mulvey
Novel substituted 4-aminomethylpiperidines as potent and selective human beta3-agonists. Part 1: aryloxypropanolaminomethylpiperidines.
Bioorganic & medicinal chemistry letters 2002;12(20):2957-61.